William S. Mezzanotte

Pulmonary Medicine

2660 W Chester Pike
Broomall, PA 19008

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.

Journal: BMJ open respiratory research

Published: May 09, 2017

Showing 1-1 of 1

Last Updated: 09/26/2026